Article
Document
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data
Information Content Entity
Academic Article
Generically Dependent Continuant
RDF description of Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data - http://irises.unibs.it/resource/item/175542